Phase II study of docetaxel, cisplatin and capecitabine as preoperative chemotherapy in resectable gastric cancer

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 10

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Gastrointest Surg. Oct 27, 2016; 8(10): 706-712
Published online Oct 27, 2016. doi: 10.4240/wjgs.v8.i10.706

Table 2 Feasibility: Treatment cycles delivered

	No. of patients	%
Cycles received
1	51	100
2	44	86.3
3	39	76.5
4	35	68.6
Percentage of intended dose delivered (per evaluable patient, ITT)¹
Docetaxel		78.90
Cisplatin		78.70
Capecitabine		78.30
Percentage of intended dose delivered in patients receiving 4 courses (n = 34)
Docetaxel		92.90
Cisplatin		92.90
Capecitabine		91.60

¹ITT: Percentage of dose delivered of all four courses divided by the amount of patients who could have received the full course.

Citation: Dassen AE, Bernards N, Lemmens VE, Wouw YAV, Bosscha K, Creemers GJ, Pruijt HJ. Phase II study of docetaxel, cisplatin and capecitabine as preoperative chemotherapy in resectable gastric cancer. World J Gastrointest Surg 2016; 8(10): 706-712
URL: https://www.wjgnet.com/1948-9366/full/v8/i10/706.htm
DOI: https://dx.doi.org/10.4240/wjgs.v8.i10.706

Dassen AE, Bernards N, Lemmens VE, Wouw YAV, Bosscha K, Creemers GJ, Pruijt HJ. Phase II study of docetaxel, cisplatin and capecitabine as preoperative chemotherapy in resectable gastric cancer. World J Gastrointest Surg 2016; 8(10): 706-712 [PMID: 27830043 DOI: 10.4240/wjgs.v8.i10.706]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.